series-b
Stage
1
Investors
About
Unnatural Products develops synthetic macrocyclic peptides using a scalable platform to create drug-like molecules targeting challenging biological pathways, bridging the gap between small molecules and biologics.
Explore Unnatural Products's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.